Director Johnson sells entire 45,379-share stake in AXGN for $1.4M across 4 trades (Dec 8–9), eliminating all holdings
Director John Johnson executed 4 separate sales over two trading days totaling 45,379 shares for $1,390,392.86, with a blended average price of $30.64, leaving him with zero post-transaction holdings. This represents a complete exit of his equity position in Axogen. The timing of the exit occurs within a volatile price environment: the stock is currently at $30.01 (9.9% below its 52-week high of $33.32) and has surged 25.0% over the prior 30 days and 78.6% over 90 days. The company has reported recent profitability ($708.0K net income in the latest quarter) and strong annual revenue growth of 17.8%, though it remains unprofitable on a full-year basis. A complete liquidation of an insider's entire shareholding warrants investor attention, particularly the decision to execute it across multiple tranches at prices near but not at peak levels during a period of significant recent appreciation.